What happens when the insulin that keeps your daughter alive suddenly disappears from the market? Alison Smart, President of Insulin Choice, reveals the shocking removal of Levamir insulin affecting over one million Americans, particularly athletes, pregnant women, and teenagers whose survival depends on this specific formulation. In this episode of Fountain of Vitality with host LaMont Leavitt, featuring Alison Smart, explore why Novo Nordick discontinued a proven insulin for weight loss drug profits, the dangerous myth that all insulin are interchangeable, and the three pathways to saving this life-sustaining medication. Alison discusses how her 13-year-old daughter's type 1 diabetes diagnosis launched a national advocacy campaign, why pregnant women face increased complications without proven insulin options, the manufacturer ready to produce Levamir with proper support, and FDA petition deadlines that could determine whether millions lose access to their only effective diabetes treatment. Learn the critical differences between basal insulin formulations, pregnancy safety concerns with alternative options, and specific actions listeners can take to prevent a healthcare crisis affecting families nationwide.